Index RUT
P/E 42.05
EPS (ttm) 3.23
Insider Own 3.26%
Shs Outstand 33.33M
Perf Week 0.78%
Market Cap 4.56B
Forward P/E 22.40
EPS next Y 6.07
Insider Trans -2.77%
Shs Float 32.45M
Perf Month 7.39%
Income 113.55M
PEG 1.95
EPS next Q 1.46
Inst Own 116.21%
Short Float 6.63%
Perf Quarter 7.26%
Sales 1.70B
P/S 2.69
EPS this Y 14.25%
Inst Trans 5.15%
Short Ratio 8.00
Perf Half Y 11.53%
Book/sh 48.33
P/B 2.81
EPS next Y 13.71%
ROA 3.81%
Short Interest 2.15M
Perf Year 52.01%
Cash/sh 1.06
P/C 128.13
EPS next 5Y 21.53%
ROE 7.42%
52W Range 84.75 - 140.91
Perf YTD 37.14%
Dividend Est. -
P/FCF 61.39
EPS past 5Y -
ROI 4.09%
52W High -3.57%
Beta 1.11
Dividend TTM -
Quick Ratio 2.09
Sales past 5Y 6.27%
Gross Margin 25.44%
52W Low 60.33%
ATR (14) 3.42
Dividend Ex-Date -
Current Ratio 3.28
EPS Y/Y TTM 38.45%
Oper. Margin 13.07%
RSI (14) 57.93
Volatility 2.15% 2.86%
Employees 10500
Debt/Eq 0.72
Sales Y/Y TTM 8.80%
Profit Margin 6.70%
Recom 1.40
Target Price 140.88
Option/Short Yes / Yes
LT Debt/Eq 0.71
EPS Q/Q 22.70%
Payout 0.00%
Rel Volume 0.51
Prev Close 133.37
Sales Surprise -2.08%
EPS Surprise 5.03%
Sales Q/Q 5.95%
Earnings Oct 24 BMO
Avg Volume 268.77K
Price 135.88
SMA20 2.72%
SMA50 4.55%
SMA200 13.30%
Trades
Volume 136,686
Change 1.88%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-16-24 Initiated
Oppenheimer
Outperform
$135
May-15-24 Initiated
Truist
Buy
$137
Apr-15-24 Upgrade
BofA Securities
Neutral → Buy
$105 → $135
Mar-14-24 Initiated
CL King
Buy
$137
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$125
May-26-23 Initiated
Wells Fargo
Equal Weight
$87
May-11-23 Initiated
Citigroup
Neutral
$88
Mar-30-23 Initiated
BofA Securities
Neutral
$86
Feb-24-23 Initiated
Piper Sandler
Overweight
$85
Jun-09-21 Upgrade
Argus
Hold → Buy
$100
Oct-07-20 Downgrade
Argus
Buy → Hold
May-14-20 Initiated
The Benchmark Company
Buy
$105
Jul-06-18 Reiterated
KeyBanc Capital Mkts
Overweight
$65 → $78
Jun-27-18 Initiated
Argus
Buy
$78
Oct-23-17 Downgrade
Northcoast
Buy → Neutral
Show Previous Ratings
Nov-14-24 09:45AM
08:00AM
Nov-01-24 07:00AM
07:00AM
Oct-29-24 09:45AM
08:29AM
Loading…
Oct-25-24 08:29AM
05:57AM
(Thomson Reuters StreetEvents)
03:11AM
Oct-24-24 08:15AM
(Associated Press Finance)
08:00AM
08:00AM
Oct-23-24 09:05AM
Oct-09-24 12:21PM
Oct-02-24 04:05PM
06:00AM
08:00AM
Loading…
Sep-30-24 08:00AM
08:00AM
Sep-26-24 08:00AM
Sep-23-24 08:00AM
Sep-20-24 09:40AM
Sep-18-24 09:45AM
Sep-10-24 09:50AM
Sep-04-24 09:40AM
Sep-02-24 09:45AM
Aug-23-24 08:18AM
Aug-22-24 08:00AM
Aug-16-24 01:23PM
Aug-01-24 07:02PM
09:50AM
08:00AM
09:45AM
Loading…
Jul-31-24 09:45AM
Jul-29-24 09:40AM
Jul-26-24 12:54PM
Jul-25-24 08:13AM
(Associated Press Finance) -7.12%
08:00AM
07:00AM
(Investor's Business Daily)
Jul-01-24 04:05PM
Jun-28-24 09:40AM
Jun-27-24 04:00PM
Jun-12-24 11:51AM
Jun-06-24 07:01PM
04:00PM
May-24-24 12:38PM
May-15-24 06:14AM
May-14-24 04:22PM
May-13-24 11:22AM
May-09-24 04:48PM
May-07-24 08:00AM
May-01-24 08:00AM
Apr-30-24 09:06AM
Apr-26-24 01:07PM
Apr-25-24 11:42PM
(Thomson Reuters StreetEvents) -9.83%
12:53PM
10:00AM
09:32AM
09:15AM
08:00AM
Apr-18-24 10:01AM
Apr-16-24 09:15AM
Apr-13-24 12:18PM
Apr-10-24 01:31PM
Apr-09-24 11:47AM
Mar-28-24 08:00AM
Mar-25-24 09:45AM
Mar-14-24 09:40AM
Mar-12-24 08:00AM
Mar-08-24 08:21AM
Feb-27-24 09:40AM
Feb-16-24 10:53AM
09:19AM
Feb-15-24 11:27PM
(Thomson Reuters StreetEvents)
08:42AM
08:12AM
(Associated Press Finance)
08:00AM
Feb-12-24 09:15AM
Feb-07-24 09:40AM
Feb-01-24 08:00AM
Jan-23-24 09:50AM
Jan-22-24 09:40AM
Jan-17-24 09:15AM
Jan-16-24 08:00AM
06:18AM
Jan-15-24 10:33AM
Jan-11-24 09:21AM
Jan-10-24 04:15PM
Jan-03-24 09:40AM
08:00AM
Dec-29-23 09:15AM
Dec-21-23 07:42AM
Dec-15-23 09:40AM
Dec-13-23 10:57AM
09:15AM
Nov-24-23 09:40AM
Nov-20-23 10:41AM
Nov-16-23 08:00AM
Nov-08-23 08:00AM
Nov-03-23 12:27PM
12:22PM
09:40AM
09:35AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hobby Jean M. Director Jul 31 '24 Option Exercise 42.29 11,385 481,508 18,265 Aug 01 04:55 PM Hobby Jean M. Director Jul 31 '24 Sale 119.66 11,960 1,431,132 2,280 Aug 01 04:55 PM MAXWELL MARTIN C Director Jul 31 '24 Sale 118.88 4,700 558,724 20,656 Aug 01 04:42 PM Harris John A EVP, Global Ops and Manufactur Jul 30 '24 Sale 123.80 3,400 420,920 1,522 Aug 01 04:38 PM Hobby Jean M. Director Jul 31 '24 Proposed Sale 119.66 11,960 1,431,132 Jul 31 01:16 PM MAXWELL MARTIN C Director Jul 31 '24 Proposed Sale 119.15 4,700 560,000 Jul 31 12:50 PM Harris John A Officer Jul 30 '24 Proposed Sale 123.80 3,400 420,920 Jul 30 02:34 PM Harris John A EVP, Global Ops and Manufactur Jun 04 '24 Sale 120.44 1,521 183,182 4,922 Jun 06 04:05 PM Hinrichs James F. Director May 24 '24 Option Exercise 44.60 9,603 428,294 17,027 May 28 03:20 PM Hinrichs James F. Director May 24 '24 Sale 122.44 9,603 1,175,772 7,424 May 28 03:20 PM Khales Payman President, C&V May 10 '24 Sale 113.84 8,712 991,739 10,431 May 14 04:08 PM Harris John A EVP, Global Ops and Manufactur May 07 '24 Sale 113.00 312 35,256 1,157 May 09 04:13 PM Senn Andrew SVP, Strategy and Business Dev May 07 '24 Sale 113.14 5,000 565,708 4,658 May 09 04:12 PM Thomas Tommy P VP, Corporate Controller Apr 30 '24 Sale 114.00 1,500 171,000 2,813 May 02 04:08 PM BAILEY PAMELA G Director Jan 02 '24 Option Exercise 40.86 1,722 70,361 51,266 Jan 03 04:26 PM Dziedzic Joseph W President & CEO Jan 02 '24 Option Exercise 40.86 1,722 70,361 159,535 Jan 03 04:24 PM
Index RUT
P/E -
EPS (ttm) -3.14
Insider Own 3.49%
Shs Outstand 37.16M
Perf Week 6.14%
Market Cap 713.84M
Forward P/E -
EPS next Y -0.91
Insider Trans 0.00%
Shs Float 36.88M
Perf Month 19.21%
Income -119.03M
PEG -
EPS next Q -0.27
Inst Own 91.38%
Short Float 6.81%
Perf Quarter 8.04%
Sales 784.25M
P/S 0.91
EPS this Y 31.88%
Inst Trans 0.99%
Short Ratio 9.62
Perf Half Y 25.62%
Book/sh 13.76
P/B 1.36
EPS next Y 67.67%
ROA -13.42%
Short Interest 2.51M
Perf Year 66.93%
Cash/sh 0.85
P/C 21.93
EPS next 5Y 9.40%
ROE -20.86%
52W Range 10.28 - 20.73
Perf YTD 38.58%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -17.73%
52W High -9.89%
Beta 1.07
Dividend TTM -
Quick Ratio 1.11
Sales past 5Y 13.08%
Gross Margin 65.83%
52W Low 81.71%
ATR (14) 0.79
Dividend Ex-Date -
Current Ratio 2.39
EPS Y/Y TTM 19.53%
Oper. Margin -10.91%
RSI (14) 59.72
Volatility 3.43% 4.38%
Employees 1634
Debt/Eq 0.30
Sales Y/Y TTM 17.32%
Profit Margin -15.18%
Recom 1.80
Target Price 24.40
Option/Short Yes / Yes
LT Debt/Eq 0.28
EPS Q/Q 8.15%
Payout -
Rel Volume 1.01
Prev Close 18.87
Sales Surprise 0.04%
EPS Surprise -105.80%
Sales Q/Q 6.85%
Earnings Nov 07 BMO
Avg Volume 260.94K
Price 18.68
SMA20 4.61%
SMA50 12.64%
SMA200 24.14%
Trades
Volume 315,304
Change -1.01%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-08-24 Upgrade
Stifel
Hold → Buy
$18 → $24
May-08-24 Upgrade
ROTH MKM
Neutral → Buy
$15 → $20
Oct-20-23 Initiated
ROTH MKM
Neutral
$12
Sep-12-23 Downgrade
Stifel
Buy → Hold
Sep-12-23 Downgrade
BTIG Research
Buy → Neutral
Jul-19-23 Resumed
BTIG Research
Buy
$27
Mar-04-22 Upgrade
Stifel
Hold → Buy
$41 → $45
Oct-20-20 Initiated
Stifel
Hold
$39
Oct-29-19 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$71 → $48
Jun-01-18 Initiated
Cantor Fitzgerald
Overweight
Jun-21-17 Initiated
BTIG Research
Buy
$52
Jun-14-17 Initiated
Ladenburg Thalmann
Buy
$53.25
May-23-17 Initiated
SunTrust
Buy
$49
Jul-10-15 Initiated
Sidoti
Buy
May-09-13 Downgrade
Mizuho
Buy → Neutral
$45 → $28
Jan-08-13 Reiterated
Mizuho
Buy
$47 → $45
Jun-21-10 Initiated
Boenning & Scattergood
Outperform
$45
Mar-09-10 Reiterated
Jefferies & Co
Buy
$38 → $40
Feb-18-10 Upgrade
Susquehanna Financial
Neutral → Positive
Jan-22-10 Initiated
Jefferies & Co
Buy
$37
Show Previous Ratings
Nov-12-24 07:05AM
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
(Associated Press Finance)
07:05AM
Loading…
07:05AM
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
05:52PM
Loading…
Aug-15-24 05:52PM
Aug-07-24 06:09AM
(Thomson Reuters StreetEvents)
Aug-06-24 08:15AM
07:17AM
(Associated Press Finance)
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
07:00AM
Loading…
May-23-24 07:00AM
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
(Thomson Reuters StreetEvents)
01:53PM
09:34AM
08:21AM
(Associated Press Finance)
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
(Thomson Reuters StreetEvents) +8.69%
Mar-05-24 10:52PM
04:42PM
(Associated Press Finance)
04:03PM
Feb-29-24 07:00AM
Feb-21-24 07:00AM
Jan-18-24 07:00AM
Jan-16-24 07:00AM
Jan-09-24 08:00AM
Jan-08-24 07:00AM
Dec-27-23 08:45AM
Dec-21-23 07:00AM
Dec-12-23 07:00AM
Dec-11-23 09:55AM
Dec-01-23 06:16PM
Nov-29-23 12:21PM
07:00AM
Nov-28-23 11:30AM
07:00AM
Nov-27-23 10:48AM
Nov-24-23 12:28PM
Nov-23-23 09:55AM
Nov-21-23 06:30PM
Nov-13-23 09:00AM
Nov-09-23 01:43PM
Nov-08-23 05:36PM
(Associated Press Finance)
04:07PM
09:00AM
Nov-07-23 03:59PM
Nov-06-23 07:00AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-31-23 01:48PM
Oct-29-23 09:00PM
Oct-23-23 09:00PM
03:54PM
Oct-18-23 09:00PM
07:00AM
Oct-17-23 08:33AM
Oct-13-23 09:00PM
08:40PM
08:23AM
Oct-12-23 09:10AM
07:00AM
Oct-09-23 05:25PM
01:48PM
Oct-08-23 09:00PM
Oct-06-23 09:13AM
Oct-02-23 09:00PM
Sep-27-23 09:00PM
Sep-21-23 09:22AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kenny Kevin J. President of Global Spine Jan 08 '24 Option Exercise 0.00 5,959 0 147,321 Jan 10 04:55 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite